How AI will destroy trust in pharma

There is no pharma business model without trust, and yet we are giving it away.

Literally giving it away, without even realising.

And it’s all because of AI.

LLMs have done amazing things to boost our content production, analysis, reporting, delivery. We can now create vast quantities of targeted materials at light speed. And our metrics are telling us these are a huge success.

But the very thing that makes them powerful, their convenience, is responsible for a dangerous erosion of our key relationships.

This whitepaper is a wake-up call to pharma leaders who are using AI unsparingly. It describes in detail how trust is managed and engaged between pharma, HCPs and patients, highlighting the areas that leaders should be aware of as these relationships break down, and what to do about it.

Because, without being alert to the erosion of trust that is already threatening many of our commercial operations, pharma could undermine itself before it realises it’s too late.

Paul Simms
CEO, Impatient Health